Brian Michael Bonnell - 06 Mar 2023 Form 4 Insider Report for ICU MEDICAL INC/DE (ICUI)

Role
Chief Financial Officer
Signature
By: Paula Darbyshire, Attorney-in-fact For: Brian M. Bonnell
Issuer symbol
ICUI
Transactions as of
06 Mar 2023
Net transactions value
-$1,233,384
Form type
4
Filing time
08 Mar 2023, 15:52:58 UTC
Previous filing
08 Mar 2022
Next filing
18 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICUI Common Stock Options Exercise $0 +1,551 +28% $0.000000 7,028 06 Mar 2023 Direct F1
transaction ICUI Common Stock Tax liability $131,580 -816 -12% $161.25 6,212 06 Mar 2023 Direct
transaction ICUI Common Stock Options Exercise $0 +8,745 +141% $0.000000 14,957 06 Mar 2023 Direct
transaction ICUI Common Stock Tax liability $742,395 -4,604 -31% $161.25 10,353 06 Mar 2023 Direct
transaction ICUI Common Stock Options Exercise $0 +2,145 +21% $0.000000 12,498 07 Mar 2023 Direct F1
transaction ICUI Common Stock Tax liability $177,784 -1,129 -9% $157.47 11,369 07 Mar 2023 Direct
transaction ICUI Common Stock Options Exercise $0 +2,209 +19% $0.000000 13,578 08 Mar 2023 Direct F1
transaction ICUI Common Stock Tax liability $181,626 -1,163 -8.6% $156.17 12,415 08 Mar 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICUI Common Stock Options Exercise $0 -1,551 -100% $0.000000* 0 06 Mar 2023 Common Stock 1,551 $0.000000 Direct F1, F2, F3, F4
transaction ICUI Common Stock Options Exercise $0 -2,209 -50% $0.000000 2,210 08 Mar 2023 Common Stock 2,209 $0.000000 Direct F1, F2, F3, F4
transaction ICUI Common Stock Options Exercise $0 -2,145 -33% $0.000000 4,291 07 Mar 2023 Common Stock 2,145 $0.000000 Direct F1, F2, F3, F4
transaction ICUI Performance Shares Options Exercise $0 -8,745 -100% $0.000000* 0 06 Mar 2023 Common Stock 8,745 Direct F5, F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are Restricted Stock Units.
F2 There is neither a purchase price nor an exercise price for the Restricted Stock Units.
F3 One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.
F4 These are restricted stock units that fully vest 3 years from the grant date.
F5 These Securities are Performance-based Restricted Stock Units (PRSU).
F6 There is neither a purchase price nor an exercise price for the PRSUs.
F7 These PRSUs were granted on March 6, 2020 and were subject to the satisfaction of both performance-based and time-based criteria. These PRSUs had a 3-year performance period and cliff-vested on the third anniversary of the grant date.